Nitric oxide and major depression

Nitric Oxide - Biology and Chemistry

Volumn 24, Issue 3, 2011, Pages 125-131

  Dhir, Ashish ^a,b   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressants; Cyclic guanosine monophosphate; l Arginine; Major depression; Nitric oxide

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARGININE; GLUTAMIC ACID; MEMANTINE; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTRANSMITTER; NITRIC OXIDE; SILDENAFIL; VENLAFAXINE;

BRAIN CORTEX; DOPAMINERGIC SYSTEM; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

5'-GUANYLIC ACID; ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; DEPRESSIVE DISORDER, MAJOR; HUMANS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 79954631683     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2011.02.002     Document Type: Review

References (54)

1. H.Y. Yun, V.L. Dawson, and T.M. Dawson Nitric oxide in health and disease of the nervous system Mol. Psychiatry 2 1997 300 310 (Pubitemid 27450312)
2. J.V. Esplugues NO as a signalling molecule in the nervous system Br. J. Pharmacol. 135 2002 1079 1095 (Pubitemid 34259107)
3. H. Li, and T.L. Poulos Structure-function studies on nitric oxide synthases J. Inorg. Biochem. 99 2005 293 305 (Pubitemid 39642983)
4. T.M. McLeod, A.L. López-Figueroa, and M.O. López-Figueroa Nitric oxide, stress, and depression Psychopharmacol. Bull. 35 2001 24 41
5. Bun-Hee Lee, Sung-Woo Lee, Dokyung Yoon, Heon-Jeong Lee, Jong-Chul Yang, Se-Hoon Shim, Do-Hoon Kim, Ryu Seung-Ho, Changsu Han, and Yong-Ku Kim Increased plasma nitric oxide metabolites in suicide attempters Neuropsychobiology 53 2006 127 132 (Pubitemid 43854170)
6. E. Suzuki, G. Yagi, T. Nakaki, S. Kanba, and M. Asai Elevated plasma nitrate levels in depressive states J. Affect Disord. 63 2001 221 224 (Pubitemid 32200517)
7. S.R. Joca, and F.S. Guimarães Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects Psychopharmacology (Berl) 185 2006 298 305
8. A. Dhir, and S.K. Kulkarni Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor Eur. J. Pharmacol. 568 2007 177 185 (Pubitemid 46976903)
9. F. Yildiz, B.F. Erden, G. Ulak, T. Utkan, and N. Gacar Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats Psychopharmacology (Berl) 149 2000 41 44 (Pubitemid 30187365)
10. O. Mutlu, G. Ulak, A. Laugeray, and C. Belzung Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice Pharmacol. Biochem. Behav. 92 2009 82 87
11. G. Wegener, V. Volke, and R. Rosenberg Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo Br. J. Pharmacol. 130 2000 575 580 (Pubitemid 30332975)
12. A. Harkin, T.J. Connor, M.P. Burns, and J.P. Kelly Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Eur. Neuropsychopharmacol. 14 2004 274 281 (Pubitemid 38649083)
13. M.S. Finkel, F. Laghrissi-Thode, B.G. Pollock, and J. Rong Paroxetine is a novel nitric oxide synthase inhibitor Psychopharmacol. Bull. 32 1996 653 658 (Pubitemid 26428269)
14. S.N. Umathe, P.S. Bhutada, N.S. Jain, Y.R. Mundhada, S.S. Borkar, and B. Dhumal Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice Nitric Oxide 21 2009 140 147
15. R.M. Oliveira, F.S. Guimarães, and J.F. Deakin Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders Braz. J. Med. Biol. Res. 41 2008 333 341 (Pubitemid 351761067)
16. B. Karolewicz, K.H. Bruce, B. Lee, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors Eur. J. Pharmacol. 372 1991 215 220
17. M.P. Kaster, P.K. Ferreira, A.R.S. Santos, and A.L.S. Rodrigues Effect of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway Behav. Brain Res. 165 2005 204 209 (Pubitemid 41565530)
18. M.L. Wong, F. Whelan, P. Deloukas, P. Whittaker, M. Delgado, R.M. Cantor, S.M. McCann, and J. Licinio Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response Proc. Natl. Acad. Sci. USA 103 2006 15124 15129 (Pubitemid 44583175)
19. G.A. Eby, and K.L. Eby Rapid recovery from major depression using magnesium treatment Med. Hypotheses 67 2006 362 370 (Pubitemid 43825609)
20. D. Pozo, R.J. Reiter, J.R. Calvo, and J.M. Guerrero Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum Life Sci. 55 1994 PL455 PL460
21. M.A. Serfaty, D. Osborne, M.J. Buszewicz, R. Blizard, and P.W. Raven A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood Int. Clin. Psychopharmacol. 25 2010 132 142
22. J. Leon, G. Escames, M.I. Rodríguez, L.C. Lopez, V. Tapias, A. Entrena, E. Camacho, M.D. Carrión, M.A. Gallo, A. Espinosa, D.X. Tan, R.J. Reiter, and D. Acuña-Castroviejo Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin J. Neurochem. 98 2006 2023 2033 (Pubitemid 44298263)
23. D. De Berardis, G. Di Iorio, T. Acciavatti, C. Conti, N. Serroni, L. Olivieri, M. Cavuto, G. Martinotti, L. Janiri, F. Saverio, M. Pio Conti, and M. Di Giannantonio The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine CNS Neurol. Disord. Drug Targets 10 2011 119 132
24. B. Karolewicz, K. Szebeni, C.A. Stockmeier, L. Konick, J.C. Overholser, G. Jurjus, B.L. Roth, and G.A. Ordway Low nNOS protein in the locus coeruleus in major depression J. Neurochem. 91 2004 1057 1066 (Pubitemid 39587444)
25. W.E. Chrapko, P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder Biol. Psychiatry 56 2004 129 134 (Pubitemid 38844788)
26. A. Ikenouchi-Sugita, Y. Toyohira, R. Yoshimura, S. Ueno, M. Tsutsui, J. Nakamura, and N. Yanagihara Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex Naunyn Schmiedebergs Arch. Pharmacol. 380 2009 479 486
27. I.A. Paul, and P. Skolnick Glutamate and depression: clinical and preclinical studies Ann. NY Acad. Sci. 1003 2003 250 272 (Pubitemid 38083061)
28. N.J. Patel, M.J. Chen, and A.A. Russo-Neustadt Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons Eur. J. Pharmacol. 633 2010 1 9
29. A. Seilicovich, M. Lasaga, M. Befumo, B.H. Duvilanski, M.D.C. Diaz, V. Rettori, and S.M. McCann Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat Proc. Natl. Acad. Sci. USA 92 1995 11299 11302
30. D.M. Kaye, S.D. Wiviott, L. Kobzik, R.A. Kelly, and T.W. Smith Regulation of neuronal (uptake-1 mediated norepinephrine transport by nitric oxide: mechanism and influence of autocrine and paracrine sources of nitric oxide Am. J. Physiol. 272 1997 H875 H883
31. A. Ikenouchi-Sugita, R. Yoshimura, H. Hori, W. Umene-Nakano, N. Ueda, and J. Nakamura Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1451 1453
32. B. Karolewicz, I.A. Paul, and L. Antkiewicz-Michaluk Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain Pol. J. Pharmacol. 53 2001 587 596
33. J. Zhang, X.Y. Huang, M.L. Ye, C.X. Luo, H.Y. Wu, Y. Hu, Q.G. Zhou, D.L. Wu, L.J. Zhu, and D.Y. Zhu Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors J. Neurosci. 30 2010 2433 2441
34. G. Ulak, O. Mutlu, P. Tanyeri, F.I. Komsuoglu, F.Y. Akar, and B.F. Erden Involvement of serotonin receptor subtypes in the antidepressant-like effect of trim in the rat forced swimming test Pharmacol. Biochem. Behav. 95 2010 308 314
35. F. Crespi The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity? Neurosci. Lett. 470 2010 95 99
36. J.P. Kiss, G. Zsilla, and E.S. Vizi Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors Neurochem. Int. 45 2004 485 489 (Pubitemid 38739475)
37. N.T. Sandor, A. Brassai, A. Pliskas, and B. Lendvai Role of nitric oxide in modulating neurotransmitter release from rat striatum Brain Res. Bull. 36 1995 483 486
38. J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system Trends Neurosci. 14 1991 60 67
39. V.L. Dawson, T.M. Dawson, E.D. London, D.S. Bredt, and S.H. Snyder Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures Proc. Natl. Acad. Sci. USA 88 1991 6368 6371 (Pubitemid 21914947)
40. K. Nei, S. Matsuyama, H. Shuntoh, and C. Tanaka NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus Brain Res. 728 1996 105 110 (Pubitemid 26254962)
41. Y. Ergun, and U.G. Ergun Prevention of pro-depressant effect of l-arginine in the forced swim test by N(G)-nitro-l-arginine and [1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one] Eur. J. Pharmacol. 554 2007 150 154 (Pubitemid 44879408)
42. A. Spiacci, F. Kanamaru, F.S. Guimarães, and R.M. Oliveira Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression Pharmacol. Biochem. Behav. 88 2008 247 255 (Pubitemid 350119843)
43. A.J. Harkin, K.H. Bruce, B. Craft, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test Eur. J. Pharmacol. 372 1999 207 213 (Pubitemid 29255959)
44. Y. Ergün, U.G. Ergün, F.O. Orhan, and E. Küük Co-administration of a nitric oxide synthase inhibitor and melatonin exerts an additive antidepressant-like effect in the mouse forced swim test Med. Sci. Monit. 12 2006 BR307 312
45. I.L. Heiberg, G. Wegener, and R. Rosenberg Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats Behav. Brain Res. 134 2002 479 484 (Pubitemid 34912725)
46. C.B. Brink, J.D. Clapton, B.E. Eagar, and B.H. Harvey Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies J. Neural Transm. 115 2008 117 125
47. A. Dhir, and S.K. Kulkarni Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 921 925 (Pubitemid 46660304)
48. S.K. Kulkarni, and A. Dhir On the mechanism of antidepressant-like action of berberine chloride Eur. J. Pharmacol. 589 2008 163 172
49. C.R. Jesse, E.A. Wilhelm, C.F. Bortolatto, J.B. Rocha, and C.W. Nogueira Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test Eur. J. Pharmacol. 635 2010 135 141
50. C.R. Jesse, C.F. Bortolatto, L. Savegnago, J.B. Rocha, and C.W. Nogueira Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1838 1843
51. M. Ghasemi, L. Montaser-Kouhsari, H. Shafaroodi, B.G. Nezami, F. Ebrahimi, and A.R. Dehpour NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test Psychopharmacology (Berl) 206 2009 325 333
52. A. Dhir, and S.K. Kulkarni Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test Indian J. Exp. Biol. 46 2008 164 170
53. R.C. Almeida, C.S. Felisbino, M.G. López, A.L. Rodrigues, and N.H. Gabilan Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice Behav. Brain Res. 168 2006 318 322 (Pubitemid 43201950)
54. A.O. Rosa, J. Lin, J.B. Calixto, A.R. Santos, and A.L. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav. Brain Res. 144 2003 87 93 (Pubitemid 37011169)